Ashwath Jayagopal insider trades

Open-market stock purchases and sales by Ashwath Jayagopal, Chief Scientific & Dev. Ofc. at Opus Genetics, Inc, from SEC Form 4 filings since Feb 12, 2024.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -34%.

Recent trades

DateStockTradeValue
Apr 23, 2026IRD Opus Genetics, IncSold$39.2K
Mar 16, 2026IRD Opus Genetics, IncSold$19K
Feb 12, 2026IRD Opus Genetics, IncSold (not open market)$18K
Jan 22, 2026IRD Opus Genetics, IncBought (not open market)—

Companies traded

  • IRD Opus Genetics, Inc: 2 sales, last Apr 23, 2026
  • OCUP Ocuphire Pharma, Inc: 1 buy, last May 22, 2024

Get free alerts when Ashwath Jayagopal files a new trade →